CYP2B6 c.223_225delinsATC ;(p.V75I)

Variant ID: 19-41509957-GTG-ATC

NM_000767.4(CYP2B6):c.223_225delinsATC;(p.V75I)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Sub-therapeutic nevirapine concentration during antiretroviral treatment initiation among children living with HIV: Implications for therapeutic drug monitoring.

Plos One
Gopalan, Bindu Parachalil BP; Mehta, Kayur K; D'souza, Reena R RR; Rajnala, Niharika N; A K, Hemanth Kumar HK; Ramachandran, Geetha G; Shet, Anita A
Publication Date: 2017

Variant appearance in text: CYP2B6: V75I
PubMed Link: 28827836
Variant Present in the following documents:
  • Main text
  • pone.0183080.pdf
View BVdb publication page



Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.

The Journal Of Antimicrobial Chemotherapy
Cozzi-Lepri, Alessandro A; Noguera-Julian, Marc M; Di Giallonardo, Francesca F; Schuurman, Rob R; Däumer, Martin M; Aitken, Sue S; Ceccherini-Silberstein, Francesca F; D'Arminio Monforte, Antonella A; Geretti, Anna Maria AM; Booth, Clare L CL; Kaiser, Rolf R; Michalik, Claudia C; Jansen, Klaus K; Masquelier, Bernard B; Bellecave, Pantxika P; Kouyos, Roger D RD; Castro, Erika E; Furrer, Hansjakob H; Schultze, Anna A; Günthard, Huldrych F HF; Brun-Vezinet, Francoise F; Paredes, Roger R; Metzner, Karin J KJ; ,
Publication Date: 2015-03

Variant appearance in text: CYP2B6: V75I
PubMed Link: 25336166
Variant Present in the following documents:
  • dku426.pdf
View BVdb publication page